Printer Friendly

Researchers' new hope in battle with leukaemia.

Byline: Emma McKinney Education Correspondent

UNIVERSITY of Birmingham scientists have discovered what they describe as a "key step" in the battle to find a cure for leukaemia.

The study by researchers has been highlighted as crucial to the process of understanding how the disease develops.

The research specifically investigated acute myeloid leukaemia and looked at the way blood cells behave in patients suffering from the illness.

The university's Professor Constanze Bonifer explained: "Stem cells in the bone marrow generate billions of different blood cells each day. The process resembles a production line with genes acting as regulators to control each step of the blood formation.

"Leukaemia arises when the DNA encoding regulators in the stem cells is changed by a mutation.

"When a mutation occurs in the relevant regulator genes, the finely balanced order of the production line is disrupted with drastic consequences.

"A chain reaction occurs, with the function of other regulators in the process being altered. The new cells no longer develop into normal blood cells, but leukemic cells that multiply and begin to take over the body."

The team, which carried out the research alongside experts from Newcastle University, used state-of-the-art technology to see how the cells change.

Professor Bonifer added, "Understanding how these rogue regulators operate is essential.

"Because all cells contain two copies of each gene, one from the mother and one from the father, these leukemic cells have one mutated gene and one unchanged one that would make the normal regulator.

"What happens in the leukemic cell is fundamentally a battle for supremacy between the two regulators, and the mutated one wins much of the time.

"This is compounded by the normal regulator which tries to compensate for defeat, and in doing so changes the output of genes that would be otherwise unaffected by the abnormal regulator.

"Quite simply, the result is a real mess. The cells are confused and can't develop into mature blood cells."

Crucially, the team identified that removing the mutated regulator allowed the cells to resume their normal behaviour and the production line returns to the regular process.

Professor Olaf Heidenreich, of Newcastle University, said: "One aberrant regulator reprograms thousands of genes. If targeting it can reverse the changes it is making to the cellular production line then it would ultimately point towards new avenues for a more precise treatment of leukaemia.

"Knowing that the production line can be restored to normal function gives us real hope. Of course, that is much easier to do in the lab that it is in the human body.

"But now we know how this works we can look to deliver inhibitors to those mutated regulators. Creating one that works is the next step we have to overcome."

Professor Heidenreich is now turning this breakthrough discovery into therapies that could provide new ways of combatting leukaemia.

The project was funded by Leukaemia and Lymphoma Research, Cancer Research UK, and the Medical Research Council.


(From left) David Bradnock (Deputy Lord Lieutenant), Tim Watts (High Sheriff <B for West Midlands), Philip Bowen (High Sheriff Powys), and Michael Hogan (Worcestershire's High Sheriff) unveil a plaque in honour of builder John Bowen
COPYRIGHT 2014 Birmingham Post & Mail Ltd
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:The Birmingham Post (England)
Date:Sep 25, 2014
Previous Article:Blue plaque unveiled for builder who helped SHAPEVICTORIAN city.
Next Article:Advice for metals firm over move.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters